Immediate Impact
1 by Nobel laureates 3 from Science/Nature 58 standout
Citing Papers
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
2023 Standout
Works of Amy Early being referenced
320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer
2020
Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Amy Early | 224 | 120 | 265 | 344 | 29 | 628 | |
| P Buchinger | 136 | 70 | 127 | 410 | 22 | 630 | |
| I M Franklin | 151 | 44 | 167 | 460 | 28 | 726 | |
| M Cadiou | 192 | 27 | 247 | 469 | 34 | 611 | |
| P.S. Mitrou | 146 | 77 | 133 | 161 | 40 | 531 | |
| Mareike Rasche | 147 | 56 | 282 | 487 | 27 | 738 | |
| Cristina Bugarin | 141 | 37 | 158 | 264 | 25 | 585 | |
| Cécile Verite | 105 | 111 | 216 | 219 | 38 | 677 | |
| M. M. Oken | 249 | 69 | 145 | 267 | 19 | 723 | |
| Uri Mintz | 138 | 60 | 140 | 284 | 34 | 688 | |
| Prentice Hg | 177 | 43 | 117 | 352 | 20 | 616 |
All Works
Loading papers...